Penn study links prostate cancer treatment to dementia : philly

as mentioned in philly

Penn study links prostate cancer treatment to dementia

Penn study links prostate cancer treatment to dementia

Here's yet another thing for men with prostate cancer to worry about.A second study has found a connection between treatments that target male hormones and dementia.Earlier research by a team from the University of Pennsylvania and Stanford University found increased risk for Alzheimer's disease.The new study, from the same institutions, published Thursday in JAMA Oncology, found that patients who had taken androgen deprivation therapy (ADT) had double the risk for a broader range of dementia diagnoses, including Alzheimer's, senile dementia, vascular dementia, and frontotemporal dementia, compared with similar men with prostate cancer who did not have the treatment.


let alone ctvnews

A new study finds pancreatic cancer develops like a 'big bang'

A new study finds pancreatic cancer develops like a 'big bang'

Misha Gajewski, CTVNews.caA new study provides insight into how pancreatic cancer develops and spreads, offering hope for better diagnosis and treatment.Many of the important changes that are thought to cause this disease happen "all at once," like a "big bang," according to researchers from the Ontario Institute for Cancer Research and University Health Network's Princess Margaret Cancer Centre.The current view is that pancreatic cancer develops gradually and sequentially but the findings published in Nature challenge this.The researchers hope that these findings could improve diagnosis and help predict how the disease will develop and when it will metastasize.


additionally cbsnews

Prostate cancer study links ADT androgen deprivation therapy with increased risk for Alzheimer's, dementia

Prostate cancer study links ADT androgen deprivation therapy with increased risk for Alzheimer's, dementia

A new study is adding to the evidence that a common prostate cancer treatment may raise a man's risk for dementia.Researchers from the University of Pennsylvania and Stanford found that a type of hormone therapy called androgen deprivation therapy (ADT) may double the risk of developing dementia.ADT is used to reduce levels of male hormones called androgens in the body and helps shrink prostate cancers.Androgens, including testosterone, stimulate the growth of prostate cancer cells.